Issue Position: Health Care and Retirement Security

Issue Position

Date: Jan. 1, 2020

Not long ago, American children and families were often denied coverage for having a pre-existing condition, millions were job-locked by their need for health coverage, and insurers could charge a woman higher premiums just for being a woman.

Not anymore. That has all changed. Led by Speaker Nancy Pelosi, Democrats -- who believe that health care is a right for all Americans, not a privilege for the few -- spearheaded the passage of the historic Affordable Care Act in 2010 that has brought about health progress for our people:

*More than 5 million seniors have saved over $3 billion on the crippling cost of prescription drugs;
*Over 100 million Americans are no longer slapped with a lifetime limit on their coverage; millions more, including 17 million children, are no longer denied coverage for having a pre-existing condition;
*2.5 million additional young adults have access to health coverage.

While Republicans cynically work to sabotage American's health care and dismantle the Affordable Care Act, Democrats will continue working to protect and improve this historic law and strengthen coverage for the American people.

We believe seniors deserve a dignified retirement. As Leader of the House Democrats, Nancy is fighting to strengthen and protect Social Security and Medicare from Donald Trump and House Republicans' fixation with destroying these vital pillars of retirement security.

Nancy Fighting Back:

A Better Deal on Prescription Drugs

Americans across the country are suffering from the skyrocketing cost of prescription drugs. They deserve better than a Republican Congress that would have made prescription drugs even harder to afford with the cruel cost increases of Trumpcare.

Leader Pelosi and Democrats offer Americans A Better Deal to reduce the cost of prescription drugs by cracking down on pharmaceutical price gouging that increases consumers' drug prices for no reason, giving Medicare Part D the ability to negotiate lower drug prices, and ensuring real transparency for excessive drop price increases.


Source
arrow_upward